Bioequivalence Study Of Glucotrol XL 2.5 Mg Tablets
Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to determine the bioequivalence of Glipizide GITS (Glucotrol
XL) 2.5 mg tablets manufactured at the Brooklyn, New York facility versus tablets
manufactured at the facility in Barceloneta, Puerto Rico.